Mumbai's Haffkine Bio-Pharma Targets 22.8 Crore Covaxin Vials A Year
NDTV
Haffkine Bio-Pharmaceutical today said it would take least at one year's time for the company to start actual production of the COVID-19 vaccines.
After receiving permission to make Bharat Biotech's COVID-19 vaccine Covaxin, Mumbai-based Haffkine Bio-Pharmaceutical today said it would take least at one year's time for the company to start actual production. A top official said the state-run company is targeting to produce 22.8 crore vials of the vaccine per year. Dr Sandeep Rathod, managing director, Haffkine Bio-Pharmaceutical Corporation Ltd, said: "Our target is to produce around 22.8 crore vaccine vials but it will take one year for us to start production." Hyderabad-based Bharat Biotech and the ICMR have developed Covaxin, one of the two vaccines being used in the ongoing nationwide COVID-19 vaccination drive.More Related News